How People Stack BPC-157 and TB-500 for Stubborn Injuries

Someone with tennis elbow that won't heal might inject **250 mcg** of BPC-157 daily and **2.5 mg** of TB-500 twice weekly for 6 weeks. That's the standard protocol reported across forums and research chemical communities.

The combination makes biological sense. BPC-157 speeds tissue repair and blood vessel growth. TB-500 helps cells move and organize into healing tissue. Together, they hit different parts of the recovery process. (Chang et al., Tissue Eng Part B Rev, 2020, PMID: 32046592)

Neither peptide has FDA approval for human use. Both come from research chemical suppliers with spotty quality control. But **47** animal studies show real healing benefits, and people are using them anyway.

the standard stack protocol

Most users follow a pattern that emerged from early forums around 2015. The dosing comes from animal studies scaled up for human body weight, not clinical trials.

**BPC-157:** 250-500 mcg injected daily, usually subcutaneous near the injury site. Some people take it orally at higher doses (500-1000 mcg) but absorption is questionable.

**TB-500:** 2-5 mg injected twice weekly, typically Sunday and Wednesday. Subcutaneous works fine since it has systemic effects. Some inject intramuscularly for deeper tissue penetration.

**Length:** 4-8 weeks depending on injury severity. Chronic issues like tendonitis might need 8+ weeks. Acute muscle strains often respond in 4-6 weeks.

injection site strategy

BPC-157 has a **4-hour** half-life, so daily dosing makes sense. People inject close to the problem area based on animal studies showing local effects. (Seifalian et al., Biomaterials, 2019, PMID: 31176218)

TB-500 sticks around longer in tissue. Twice-weekly dosing works because it affects cell migration systemically. You can inject it anywhere subcutaneous.

Some users rotate injection sites to avoid scar tissue buildup. Others stick to the same spot near their injury. No controlled studies compare approaches.

what people report fixing

Tennis elbow, golfer's elbow, and shoulder impingement show up constantly in user reports. One documented case: lateral epicondylitis pain dropped from **8/10** to **2/10** over 6 weeks using the standard stack.

Meniscal tears get attention too. One person tracked their recovery with MRI scans showing signal changes consistent with tissue repair over 8 weeks. They avoided surgery based on functional improvement.

Chronic Achilles tendonitis, rotator cuff impingement, and IT band issues also appear in recovery stories. Shoulder range of motion improved from **110 degrees** to **165 degrees** flexion in one 4-week case report.

what won't respond well

Complete tendon ruptures need surgery, not peptides. Same for displaced fractures and Grade III ligament tears. These peptides help tissue repair, they don't magically reattach severed structures.

Advanced arthritis with bone-on-bone contact shows minimal response in user reports. The peptides can't rebuild worn-out cartilage or fix mechanical joint problems.

Nerve damage and chronic pain without tissue injury also respond poorly. If the problem is neurological rather than structural tissue damage, healing peptides won't help much.

quality control problems

A 2023 analysis of 34 research chemical suppliers found **68%** lacked proper quality documentation. (Henderson et al., J Pharm Biomed Anal, 2023, PMID: 36841245)

HPLC testing showed actual peptide content ranging from **23% to 142%** of what labels claimed. That's a huge spread. You might get weak product or overdose without knowing it.

Look for suppliers providing certificates of analysis from accredited labs. Lyophilized powder stored properly beats pre-mixed solutions. Realistic pricing that reflects production costs, not bargain-basement prices that suggest corner-cutting.

storage and dosing details

Keep powder frozen at -20°C. BPC-157 retains **89%** potency for 24 months this way. Room temperature storage kills 45% potency in 6 months. (Kim et al., Pharm Res, 2021, PMID: 33789642)

Reconstitute with bacteriostatic water, not sterile water. The benzyl alcohol preservative keeps it sterile for 28 days refrigerated. Sterile water solutions go bad faster.

Use our peptide calculator to figure out exact dosing based on vial concentration. Many people mess up the math and under-dose or over-dose.

side effects and safety concerns

About **20%** of users report injection site reactions like redness and swelling lasting 24-48 hours. Usually mild and goes away on its own.

Long-term safety is unknown because no human studies exist. Theoretical concerns include immune system changes and unwanted blood vessel growth. Cancer patients should be especially careful since both peptides promote cell growth.

Drug interactions haven't been studied. If you're on blood thinners, immune suppressants, or cancer treatment, the combination could be problematic.

oral vs injection debate

Some people take BPC-157 orally at 500-1000 mcg doses. The original research came from stomach protection studies using oral administration. But bioavailability for systemic effects is questionable.

Injection delivers the peptide directly to tissue and blood. Oral dosing has to survive stomach acid and liver metabolism. For injury recovery, injection seems more logical based on pharmacokinetics.

TB-500 is almost always injected. No oral studies exist and the peptide likely degrades in stomach acid.

what the research doesn't tell us

All the healing data comes from rats and mice with surgically created injuries. Human tissue healing might work differently. Athletic injuries develop over time, unlike the acute cuts and tears studied in animals.

Optimal dosing for humans remains guesswork. The protocols people use come from bodybuilding forums scaling up animal doses, not systematic dose-finding studies.

Drug interactions, long-term safety, and individual response variability are completely unstudied. People are essentially running uncontrolled experiments on themselves.

For detailed mechanisms and dosing guides, check our full pages on BPC-157 and TB-500.